Mutations in the gene encoding gap junction protein alpha 12 (connexin 46.6) cause Pelizaeus-Merzbacher-like disease.
暂无分享,去创建一个
Peter Nürnberg | Markus Schuelke | Franz Rüschendorf | Bernhard Weschke | B. Weschke | M. Schuelke | F. Rüschendorf | P. Nürnberg | B. Uhlenberg | N. Ruf | A. Kaindl | M. Henneke | H. Thiele | G. Stoltenburg‐Didinger | Fuat Aksu | H. Topaloglu | C. Hübner | J. Gärtner | Holger Thiele | Jutta Gärtner | Haluk Topaloğlu | Marco Henneke | Angela M Kaindl | Birgit Uhlenberg | Nico Ruf | Gisela Stoltenburg-Didinger | Fuat Aksu | Christoph Hübner | H. Topaloğlu
[1] G. Kraft,et al. Proteolipid Protein Is Necessary in Peripheral as Well as Central Myelin , 1997, Neuron.
[2] J. Rash,et al. Astrocyte and Oligodendrocyte Connexins of the Glial Syncytium in Relation to Astrocyte Anatomical Domains and Spatial Buffering , 2003, Cell communication & adhesion.
[3] B. Dastugue,et al. Genotype–phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations , 2000, European Journal of Human Genetics.
[4] J R O'Connell,et al. PedCheck: a program for identification of genotype incompatibilities in linkage analysis. , 1998, American journal of human genetics.
[5] C. Bolton,et al. Clinical and pathological observations in men lacking the gap junction protein connexin 32 , 2000, Muscle & nerve. Supplement.
[6] Nicolas Produit,et al. Parametric and nonparametric multipoint linkage analysis with imprinting and two-locus-trait models: application to mite sensitization. , 2000, American journal of human genetics.
[7] J. Degen,et al. Structural and Functional Diversity of Connexin Genes in the Mouse and Human Genome , 2002, Biological chemistry.
[8] L. Hudson. Pelizaeus-Merzbacher Disease and Spastic Paraplegia Type 2 , 2003, Journal of child neurology.
[9] K. Wellershaus,et al. Connexin 47 (Cx47)-Deficient Mice with Enhanced Green Fluorescent Protein Reporter Gene Reveal Predominant Oligodendrocytic Expression of Cx47 and Display Vacuolized Myelin in the CNS , 2003, Journal of Neuroscience.
[10] T. Lehner,et al. Pelizaeus-Merzbacher-like disease: Exclusion of the proteolipid protein locus and documentation of a new locus on Xq , 1997, Neurology.
[11] A. Taylor,et al. trans-dominant inhibition of connexin-43 by mutant connexin-26: implications for dominant connexin disorders affecting epidermal differentiation. , 2001, Journal of cell science.
[12] S. Scherer,et al. Cellular mechanisms of connexin32 mutations associated with CNS manifestations , 2002, Journal of neuroscience research.
[13] R. Schiffmann,et al. An update on the leukodsytrophies , 2001, Current opinion in neurology.
[14] N. Gilula,et al. Specific amino-acid residues in the N-terminus and TM3 implicated in channel function and oligomerization compatibility of connexin43 , 2003, Journal of Cell Science.
[15] J. Degen,et al. Functional Expression of the New Gap Junction Gene Connexin47 Transcribed in Mouse Brain and Spinal Cord Neurons , 2001, The Journal of Neuroscience.
[16] K. Arimura,et al. Gap junction protein beta 1 (GJB1) mutations and central nervous system symptoms in X‐linked Charcot–Marie–Tooth disease , 2003, Acta neurologica Scandinavica.
[17] Bernd Wollnik,et al. Connexin 43 (GJA1) mutations cause the pleiotropic phenotype of oculodentodigital dysplasia. , 2003, American journal of human genetics.
[18] D. Paul,et al. Connexins Are Critical for Normal Myelination in the CNS , 2003, The Journal of Neuroscience.
[19] G. Abecasis,et al. Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.
[20] C. Naus,et al. Epileptiform activity in hippocampal slice cultures exposed chronically to bicuculline: increased gap junctional function and expression , 2003, Journal of neurochemistry.
[21] K. Fischbeck,et al. Transient central nervous system white matter abnormality in X‐linked Charcot‐Marie‐Tooth disease , 2002, Annals of neurology.
[22] K. Fischbeck,et al. Connexin32‐null mice develop demyelinating peripheral neuropathy , 1998, Glia.
[23] K. Zerres,et al. Transient, recurrent, white matter lesions in X-linked Charcot-Marie-Tooth disease with novel connexin 32 mutation. , 2003, Archives of neurology.
[24] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[25] K. Fischbeck,et al. Connexin mutations in X-linked Charcot-Marie-Tooth disease. , 1993, Science.
[26] H. Osaka,et al. Pelizaeus-Merzbacher-like disease: female case report , 1996, Brain and Development.
[27] J. Rash,et al. Coupling of astrocyte connexins Cx26, Cx30, Cx43 to oligodendrocyte Cx29, Cx32, Cx47: Implications from normal and connexin32 knockout mice , 2003, Glia.
[28] M. Shoji,et al. Deletion and nonsense mutations of the connexin 32 gene associated with Charcot-Marie-Tooth disease. , 1999, The Tohoku journal of experimental medicine.
[29] E. Moser,et al. Degree of hypomyelination and magnetic resonance spectroscopy findings in patients with Pelizaeus Merzbacher phenotype. , 2003, Neuropediatrics.
[30] A. Koeppen,et al. Pelizaeus‐Merzbacher Disease , 2002, Journal of neuropathology and experimental neurology.